Disorder "Sickle Cell Anemia"
Found 352 records
Disorder information
Disorder name:
Sickle Cell Anemia 
Disoder ID:
OMIM entry:
Synonyms:
Hb SC disease,Hb-S/Hb-C disease,Hb-SS disease without crisis,Hemoglobin S disease without crisis,Sickle-cell/Hb-C disease without crisis,drepanocytosis,hemoglobin SC disease 
Definition:
Sickle cell anemias are chronic hemolytic diseases that may induce three types of acute accidents: severe anemia, severe bacterial infections, and ischemic vasoocclusive accidents (VOA) caused by sickle-shaped red blood cells obstructing small blood vessels and capillaries. Many diverse complications can occur. 
Modifier statisitcs
Record:
352 
Gene:
110 
Variant:
291 
Reference:
43 
Effect type:
Expressivity(325) ,Pleiotropy(22) ,Penetrance(4) ,Dominance(1)  
Modifier effect:
Risk factor(104) ,Altered HbF levels(76) ,Altered response to hydroxyurea(32) ,Altered HbF production(25) ,Altered severity(17) ,Bacteremia-prone phenotype(13) ,Altered white blood cell counts(11) ,Altered baseline HbF level(10) ,Altered hemoglobin level(9) ,Altered fetal hemoglobin (HbF) levels(8) ,Altered levels of fetalhemoglobin and pain crisis(8) ,Altered glomerular filtration rate(6) ,Altered stroke susceptibility(6) ,Altered anemia, leukocytosis, and thrombocytosis(4) ,Altered incidence(4) ,Altered level of Fetal hemoglobin(3) ,Altered levels of HbF(3) ,Altered susceptibility(2) ,Altered serum levels(2) ,Presence of albuminuria(2) ,Alter the occurrence of stroke(1) ,Altered HbF levele(1) ,Altered bilirubin level(1) ,Altered immune response(1) ,Altered level of fetal hemoglobin(1) ,Altered rate of hospitalization(1) ,Heterozygote susceptibility(1)  
Modifier gene Variant Effect type Modifier effect Evidence Effect PubMed ID
BMP6 BMP6:c.857+3770T>A Expressivity  Risk factor  P=0.0023; RR=2.42  The patients carried genotype TA of rs 267196 and genotype AG of rs267201 present a high risk factor for developing osteonecrosismore more
BMP6:c.857+8026A>G Expressivity  Risk factor  Bayesian approach  31 SNPs in 12 genes interact with fetal hemoglobin to modulate the risk of strokemore more
BMP6:c.857+8026A>G Expressivity  Risk factor  P=0.019  A multiple regression model, which included age and baseline hemoglobin as covariates, retained SNPs in ACVRL1, BMP6, and ADRB1 as independently contributing to pHTN risk.more more
BMP6:c.857+8026A>G Expressivity  Risk factor  P=0.041; RR=2.24  The patients carried genotype TA of rs 267196 and genotype AG of rs267201 present a high risk factor for developing osteonecrosismore more
BCLAF1 BCLAF1:c.-115+1501G>A Expressivity  Altered baseline HbF level  P<0.05  The polymorphisms may harbor trans-acting elements that help modulate baseline HbF level in sickle cell anemia.more more
BCL11A BCL11A:c.386-18893T>G Expressivity  Risk factor  Frequently observed mutations  The 4 markers (rs6545816, rs1427407, rs66650371, and rs7482144) each independently contributing HbF-boosting allelesmore more
BCL11A:c.386-18893T>G Expressivity  Altered HbF levels  P=0.02  Common variants for BCL11A and HBS1L-MYB were strongly associated with HbF levels.more more
BCL11A:c.386-22075A>C Expressivity  Risk factor  Frequently observed mutations  The 4 markers (rs6545816, rs1427407, rs66650371, and rs7482144) each independently contributing HbF-boosting allelesmore more
BCL11A:c.386-22075A>C Expressivity  Altered HbF levels  P=7.0×10(-10)  Common variants for BCL11A and HBS1L-MYB were strongly associated with HbF levels.more more
BCL11A:c.386-22075A>C Expressivity  Altered HbF production  P=9.12×10(-6)  Possible molecular determinants of HbF productionmore more
Total 352,Each Page
,Jump To
Page